Dr. Shawn Kile is a board-certified neurologist with expertise in treating cognitive disorders. He cares for patients with dementia, traumatic brain injury, autism, encephalopathy, and other neurocognitive illnesses. Dr. Kile has authored numerous publications and presented internationally on new approaches to managing Alzheimer’s disease, dementia, neurobehavioral disorders and traumatic brain injury. He is a Principal Investigator for physician-initiated trials supported by the Sutter Institute for Medical Research (SIMR) and phase 2-3 clinical studies assessing the efficacy of new therapies for Alzheimer’s disease and adult autism.
Sutter Health Research Enterprise
2800 L Street, Suite 500
Sacramento, CA, 95816
(916) 454-6850
simr@sutterhealth.org
Primary Research Interests
Related Clinical Trials
247AD201 CELIA
A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD)
Investigator: Shawn Kile MD
Status: Active, Not Recruiting
APOLLOE4
An Efficacy and Safety Study of ALZ-801 in APOE4/?4 Early AD Subjects (APOLLOE4)
Investigator: Shawn Kile MD
Status: Active, Not Recruiting
NVI-039 AD
Proof of Concept of the Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment due to Alzheimer’s Disease
Investigator: Shawn Kile MD
Status: Active, Recruiting
Publications
IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia
To determine the effect of intravenous immunoglobulin on brain atrophy and cognitive function in mild cognitive impairment due to Alzheimer's disease
Brain regions showing increased activation by threat-related words in panic disorder.
Brain regions showing increased activation by threat-related words in panic disorder.
Neuropsychiatric update: neuroimaging schizophrenia.
Neuropsychiatric update: neuroimaging schizophrenia.
Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease
Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease
Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment
Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment
Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease
Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease